Milk of Magnesia Demonstration Classifying Matter and Physical Versus Chemical Changes SCIENTIFIC
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Chemicals Used for Chemical Manufacturing Page 1 of 2
Chemicals used for Chemical Manufacturing Page 1 of 2 Acetic Acid (Glacial, 56%) Glycol Ether PMA Acetone Glycol Ether PNB Acrylic Acid Glycol Ether PNP Activated Carbon Glycol Ether TPM Adipic Acid Glycols Aloe Vera Grease Aluminum Stearate Gum Arabic Aluminum Sulfate Heat Transfer Fluids Amino Acid Heptane Ammonium Acetate Hexane Ammonium Bicarbonate Hydrazine Hydrate Ammonium Bifluoride Hydrochloric Acid (Muriatic) Ammonium Chloride Hydrogen Peroxide Ammonium Citrate Hydroquinone Ammonium Hydroxide Hydroxylamine Sulfate Ammonium Laureth Sulfate Ice Melter Ammonium Lauryl Sulfate Imidazole Ammonium Nitrate Isobutyl Acetate Ammonium Persulfate Isobutyl Alcohol Ammonium Silicofluoride Calcium Stearate Dipropylene Glycol Isopropanolamine Ammonium Sulfate Carboxymethylcellulose Disodium Phosphate Isopropyl Acetate Antifoams Caustic Potash D'Limonene Isopropyl Alcohol Antifreeze Caustic Soda (All Grades) Dodecylbenzene Sulfonic Acid Isopropyl Myristate Antimicrobials Caustic Soda (Beads, Prills) (DDBSA) Isopropyl Palmitate Antimony Oxide Cetyl Alcohol Dowfrost Itaconic Acid Aqua Ammonia Cetyl Palmitate Dowfrost HD Jojoba Oil Ascorbic Acid Chlorine, Granular Dowtherm SR-1 Keratin Barium Carbonate Chloroform Dowtherm 4000 Lactic Acid Barium Chloride Chromic Acid EDTA Lanolin Beeswax Citric Acid (Dry and Liquid) EDTA Plus Lauric Acid Bentonite Coal Epsom Salt Lauryl Alcohol Benzaldehyde Cocamide DEA Ethyl Acetate Lecithin Benzoic Acid Copper Nitrate Ethyl Alcohol (Denatured) Lime Benzyl Alcohol Copper Sulfate Ethylene Glycol Linoleic Acid Bicarbonate -
Magnesium Sulfate
MAGNESIUM SULFATE Prepared at the 68th JECFA (2007), published in FAO JECFA Monographs 4 (2007), superseding the specifications prepared at the 63rd JECFA (2004) and published the Combined Compendium of Food Additive Specifications, FAO JECFA Monographs 1 (2005). An ADI “not specified” was established at the 68th JECFA (2007). SYNONYMS Epsom salt (heptahydrate); INS No.518 DEFINITION Magnesium sulfate occurs naturally in sea water, mineral springs and in minerals such as kieserite and epsomite. It is recovered from them or by reacting sulfuric acid and magnesium oxide. It is produced with one or seven molecules of water of hydration or in a dried form containing the equivalent of between 2 and 3 waters of hydration. Chemical names Magnesium sulfate C.A.S. number Monohydrate: 14168-73-1 Heptahydrate: 10034-99-8 Dried: 15244-36-7 Chemical formula Monohydrate: MgSO4.H2O Heptahydrate: MgSO4.7H2O Dried: MgSO4.xH2O, where x is the average hydration value (between 2 and 3) Formula weight Monohydrate: 138.38 Heptahydrate: 246.47 Assay Not less than 99.0 % and not more than 100.5% on the ignited basis DESCRIPTION Colourless crystals, granular crystalline powder or white powder. Crystals effloresce in warm, dry air. FUNCTIONAL USES Nutrient; flavour enhancer; firming agent; and processing aid (fermentation aid in the production of beer and malt beverages) CHARACTERISTICS IDENTIFICATION Solubility (Vol. 4) Freely soluble in water, very soluble in boiling water, and sparingly soluble in ethanol. Test for magnesium (Vol. 4) Passes test Test for sulfate (Vol. 4) Passes test PURITY Loss on ignition (Vol. 4) Monohydrate: between 13.0 and 16.0 %, Heptahydrate: between 40.0 and 52.0 %, Dried: between 22.0 and 32.0 % (105°, 2h, then 400° to constant weight) pH (Vol. -
Mechanosynthesis of Magnesium and Calcium Salt?Urea Ionic Cocrystal
Letter pubs.acs.org/journal/ascecg Mechanosynthesis of Magnesium and Calcium Salt−Urea Ionic Cocrystal Fertilizer Materials for Improved Nitrogen Management Kenneth Honer, Eren Kalfaoglu, Carlos Pico, Jane McCann, and Jonas Baltrusaitis* Department of Chemical and Biomolecular Engineering, Lehigh University, B336 Iacocca Hall, 111 Research Drive, Bethlehem, Pennsylvania 18015, United States *S Supporting Information ABSTRACT: Only 47% of the total fertilizer nitrogen applied to the environment is taken up by the plants whereas approximately 40% of the total fertilizer nitrogen lost to the environment reverts back into unreactive atmospheric dinitrogen that greatly affects the global nitrogen cycle including increased energy consumption for NH3 synthesis, as well as accumulation of nitrates in drinking water. In this letter, we provide a mechanochemical method of inorganic magnesium and calcium salt−urea ionic cocrystal synthesis to obtain enhanced stability nitrogen fertilizers. The solvent-free mechanochemical synthesis presented can result in a greater manufacturing process sustainability by reducing or eliminating the need for solution handling and evaporation. NH3 emission testing suggests that urea ionic cocrystals are capable of decreasing NH3 emissions to the environment when compared to pure urea, thus providing implications for a sustainable global solution to the management of the nitrogen cycle. KEYWORDS: Fertilizers, Nitrogen, urea, Mechanochemistry, Cocrystal, pXRD, NH3 Emissions, Stability ■ INTRODUCTION ammonia as opposed to up to 61.1% of soil treated with urea 7,8 fi only, which suggests that major improvements to the global Atmospheric dinitrogen, N2, xation to synthesize ammonia, 9,10 ’ 1 nitrogen cycle are achievable. Additionally, urea molecular NH3, consumes more than 1% of the world s primary energy. -
Potassium-Magnesium Citrate Is an Effective Prophylaxis Against Recurrent Calcium Oxalate Nephrolithiasis
0022-5347/97/1586-2069$03.00/0 JOURNAL OF UROLOGY Vol. 158,2069-2073, December 1997 Copyright Q 1997 by AMERICANUROLOGICAL ASS~CIATION, INC. Printed in U.S.A. POTASSIUM-MAGNESIUM CITRATE IS AN EFFECTIVE PROPHYLAXIS AGAINST RECURRENT CALCIUM OXALATE NEPHROLITHIASIS BRUCE ETTINGER,* CHARLES Y. C. PAK, JOHN T. CITRON, CARL THOMAS, BEVERLEY ADAMS-HIJET AND ARLINE VANGESSEL From the Diuision of Research, Kaiser Permanente Medical Care Program, Oakland, California, the Department of Mineral Metabolism, Center for Mineral Metabolism and Clinical Research, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas, Department of Medicine, Kaiser Permanente Medical Center, Walnut Creek, California, Department of Urology, Kaiser Permanente Medical Center, San Francisco, California, and Kaiser Foundation Research Institute, Kaiser Foundation Hospitals, Oakland, California ABSTRACT Purpose: We examined the efficacy of potassium-magnesium citrate in preventing recurrent calcium oxalate kidney calculi. Materials and Methods: We conducted a prospective double-blind study of 64 patients who were randomly assigned to receive placebo or potassium-magnesium citrate (42 mEq. potassium, 21 mEq. magnesium, and 63 mEq. citrate) daily for up to 3 years. Results. New calculi formed in 63.6%of subjects receiving placebo and in 12.9%of subjects receiving potassium-magnesiumcitrate. When compared with placebo, the relative risk of treat- ment failure for potassium-magnesium citrate was 0.16 (95%confidence interval 0.05 to 0.46). potassium-magnesium citrate had a statistically significant effect (relative risk 0.10,95%confi- dence interval 0.03 to 0.36) even after adjustment for possible confounders, including age, pretreatment calculous event rate and urinary biochemical abnormalities. -
The Importance of Minerals in the Long Term Health of Humans Philip H
The Importance of Minerals in the Long Term Health of Humans Philip H. Merrell, PhD Technical Market Manager, Jost Chemical Co. Calcium 20 Ca 40.078 Copper 29 Cu 63.546 Iron Magnesium 26 12 Fe Mg 55.845 24.305 Manganese Zinc 25 30 Mn Zn 55.938 65.380 Table of Contents Introduction, Discussion and General Information ..................................1 Calcium ......................................................................................................3 Copper .......................................................................................................7 Iron ...........................................................................................................10 Magnesium ..............................................................................................13 Manganese ..............................................................................................16 Zinc ..........................................................................................................19 Introduction Daily intakes of several minerals are necessary for the continued basic functioning of the human body. The minerals, Calcium (Ca), Iron (Fe), Copper (Cu), Magnesium (Mg), Manganese (Mn), and Zinc (Zn) are known to be necessary for proper function and growth of the many systems in the human body and thus contribute to the overall health of the individual. There are several other trace minerals requirements. Minimum (and in some cases maximum) daily amounts for each of these minerals have been established by the Institute of -
Laxatives for the Management of Constipation in People Receiving Palliative Care (Review)
View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by UCL Discovery Laxatives for the management of constipation in people receiving palliative care (Review) Candy B, Jones L, Larkin PJ, Vickerstaff V, Tookman A, Stone P This is a reprint of a Cochrane review, prepared and maintained by The Cochrane Collaboration and published in The Cochrane Library 2015, Issue 5 http://www.thecochranelibrary.com Laxatives for the management of constipation in people receiving palliative care (Review) Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd. TABLE OF CONTENTS HEADER....................................... 1 ABSTRACT ...................................... 1 PLAINLANGUAGESUMMARY . 2 BACKGROUND .................................... 2 OBJECTIVES ..................................... 4 METHODS ...................................... 4 RESULTS....................................... 7 Figure1. ..................................... 8 Figure2. ..................................... 9 Figure3. ..................................... 10 DISCUSSION ..................................... 13 AUTHORS’CONCLUSIONS . 14 ACKNOWLEDGEMENTS . 14 REFERENCES ..................................... 15 CHARACTERISTICSOFSTUDIES . 17 DATAANDANALYSES. 26 ADDITIONALTABLES. 26 APPENDICES ..................................... 28 WHAT’SNEW..................................... 35 HISTORY....................................... 35 CONTRIBUTIONSOFAUTHORS . 36 DECLARATIONSOFINTEREST . 36 SOURCESOFSUPPORT . 36 DIFFERENCES -
Sulfate Resistance Study of Carbonated Low-Calcium Silicate Systems
Sixth International Conference on Durability of Concrete Structures Paper Number PSE12 18 - 20 July 2018 University of Leeds, Leeds, West Yorkshire, LS2 9JT, United Kingdom Sulfate Resistance Study of Carbonated Low-Calcium Silicate Systems R. Tokpatayeva and J. Olek Lyles School of Civil Engineering, Purdue University, West Lafayette, IN, USA J. Jain, A. Seth and N. DeCristofaro Solidia Technologies Inc., Piscataway, NJ, USA ABSTRACT This paper summarizes the results of sulfate resistance study of carbonated mortar specimens made with Solidia Cement (SC) and tested for expansion according to ASTM C1012 specification while exposed to three types of soak solutions: sodium sulfate, magnesium sulfate and deionized water. A control set of ordinary portland cement (OPC) mortars was also evaluated. Besides the length change measurements, visual observations of changes in the appearance of specimens were conducted after various lengths of exposure. In addition, microstructural characterization of the specimens was conducted using scanning electron microscopy (SEM), X-ray diffraction (XRD) and thermo-gravimetric analysis (TGA) techniques. Finally, changes in the concentration of the chemical species present in the soak solutions in contact with the SC specimens were evaluated using both, the ion chromatography (IC) and the inductively coupled plasma optical emission spectrometry (ICP-OES). As expected, the OPC mortar specimens started deteriorating early and reached the critical (i.e.0.1%) level of expansion in about 4 months in case of sodium sulfate solution and in about 6 months in case of magnesium sulfate solution. With respect to the SC mortar specimens, those exposed to magnesium sulfate solution showed higher expansion than those exposed to sodium sulfate solution. -
Cycle Stability and Hydration Behavior of Magnesium Oxide and Its Dependence on the Precursor-Related Particle Morphology
nanomaterials Article Cycle Stability and Hydration Behavior of Magnesium Oxide and Its Dependence on the Precursor-Related Particle Morphology Georg Gravogl 1,2, Christian Knoll 2,3 , Jan M. Welch 4, Werner Artner 5, Norbert Freiberger 6, Roland Nilica 6, Elisabeth Eitenberger 7, Gernot Friedbacher 7, Michael Harasek 3 , Andreas Werner 8, Klaudia Hradil 5, Herwig Peterlik 9, Peter Weinberger 2 , Danny Müller 2,* and Ronald Miletich 1 1 Department of Mineralogy and Crystallography, University of Vienna, Althanstraße 14, 1090 Vienna, Austria; [email protected] (G.G.); [email protected] (R.M.) 2 Institute of Applied Synthetic Chemistry, TU Wien, Getreidemarkt 9, 1060 Vienna, Austria; [email protected] (C.K.); [email protected] (P.W.) 3 Institute of Chemical, Environmental & Biological Engineering, TU Wien, Getreidemarkt 9, 1060 Vienna, Austria; [email protected] 4 Atominstitut, TU Wien, Stadionallee 2, 1020 Vienna, Austria; [email protected] 5 X-ray Center, TU Wien, Getreidemarkt 9, 1060 Vienna, Austria; [email protected] (W.A.); [email protected] (K.H.) 6 RHI-AG, Magnesitstraße 2, 8700 Leoben, Austria; [email protected] (N.F.); [email protected] (R.N.) 7 Institute of Chemical Technologies and Analytics, TU Wien, Getreidemarkt 9, 1060 Vienna, Austria; [email protected] (E.E); [email protected] (G.F.) 8 Institute for Energy Systems and Thermodynamics, TU Wien, Getreidemarkt 9, 1060 Vienna, Austria; [email protected] 9 Faculty of Physics, University of Vienna, Boltzmanngasse 5, 1090 Vienna, Austria; [email protected] * Correspondence: [email protected]; Tel.: +43-1-5880-1163-740 Received: 31 August 2018; Accepted: 2 October 2018; Published: 7 October 2018 Abstract: Thermochemical energy storage is considered as an auspicious method for the recycling of medium-temperature waste heat. -
Impact of a Drugs & Therapeutics Backgrounder on Docusate Utilization
Impact of a Drugs & Therapeutics Backgrounder on Docusate Utilization Darren Pasay, B.Sc.Pharm Drug Stewardship Pharmacist (Central Zone) [email protected] Disclosure I have no actual or potential conflict of interest in relation to this topic or presentation. Drug Stewardship in Alberta Health Services • Drug Stewardship (DS) Team established in 2012 • “The shared responsibility of Drugs & Safety Therapeutics Committee (DTC), prescribers, pharmacy and care units to ensure Sustainability medications are used in a manner that maximizes the effectiveness, safety and sustainability of care for our patients” Effectiveness • Research and project support Drugs & Therapeutics Backgrounders (DTBs) • Frontline staff wanted background and support on DTC/formulary issues1 • One page document, meant to enhance conversations with prescribers • Supported by content experts, based upon DTC directions • Published 6 times/year • Followed by 2 interactive webinars for each edition 1. Pasay Darren K, Chow Sheldon JS, Bresee Lauren C, Guirguis Micheal, Slobodan Jeremy. Assessment of current antimicrobial stewardship policies and resources: a focus group project. Healthcare Infection 2015; 20: 7–15. Docusate • Over-the-counter stool softener • It is clear, based on published peer-reviewed literature, that docusate is ineffective for the prevention or treatment of constipation • Open listed on AHS Provincial Drug Formulary • Limited coverage on Alberta Drug Benefit List (palliative care only) Docusate DTB • Preliminary work o ~ 2 million doses/year dispensed • Influences o Some LTC sites have eliminated o Engrained in practice use already • Part of pharmacy, medicine, nursing curriculums • Order sets, Pre-printed care • What are the costs of? orders (PPCO) o Procurement o Seen as innocuous, safe o Processing, dispensing o Medication administration o Medication burden BOTTOM LINE: Docusate is no more effective than placebo for the prevention and treatment of constipation. -
United States Patent Office Patented Nov
3,539,306 United States Patent Office Patented Nov. 10, 1970 2 properties of quick activity, durable effect and storage 3,539,306 PROCESS FOR THE PREPARATION Stability, and that, therefore, the same can provide an ex OF HYDROTALCITE cellent, ideal antacid. Teruhiko Kumura and Norio Imataki, Takamatsu-shi, Hydrotalcite is known as a mineral having a chemical Katuyuki Hasui, Kagawa-ken, and Takeo Inoue and 5 Structure of the formula Kimiaki Yasutomi, Nagao-machi, Kagawa-ken, Japan, assignors to Kyowa Chemical Industry Co., Ltd., Tokyo, MgAl(OH) 16CO3 4HO O Al2O3 6MgO CO2: 12H2O Japan, a corporation of Japan No Drawing. Filed July 21, 1967, Ser. No. 654,977 which has been naturally produced in only very limited Claims priority, application Japan, July 25, 1966, areas as Norway and Ural. Also a process for the syn 41/48,349; July 17, 1967, 42/45,658 O thesis of hydrotalcite was disclosed, which comprises add Int. C. COf 5/00, 7/00, A61k 27/06 ing Dry Ice or ammonium carbonate to a mixture of U.S. C. 23-315 4 Claims magnesium oxide and y-alumina or the thermal decom position product from of magnesium nitrate and aluminum nitrate, and thereafter maintaining the system at tempera ABSTRACT OF THE DISCLOSURE, tures below 325 C. and under elevated pressures of total A process for the preparation of hydrotalcite which 2,000-20,000 p.s.i. (Roy et al.: American Journal of comprises mixing an alumium component such as alumi Science 251, 350-353 (1953)). However this process is num Salt With a magnesium component such as magnesium obviously unpractical for industrial scale production of Salt in an aqueous medium in the presence of carbonate hydrotalcite, because the reaction system must be main ion at a pH of at least 8 and thereafter recovering the 20 tained under considerably high pressures. -
Managing Ferret Toxicoses J
CLINICIAN’S NOTEBOOK Managing Ferret Toxicoses J. RICHARDSON AND R. BALABUSZKO Jill A. Richardson, DVM, Dipl ACFE ASPCA National Animal Poison Control Center 1717 South Philo Road Suite 36 Urbana, Illinois 61802 [email protected] FERRETS ARE EXTREMELY CURIOUS and adept at accessing areas where PRACTICE TIP baits, cleaners, chemicals and medica- Rachel A. Balabuszko, CVT tions are stored. Ferrets can even pry ASPCA National Animal Poison caps from child-resistant bottles or Control Center chew through heavy plastic contain- ers. Products such as antifreeze, Dr. Jill A. Richardson received her DVM flavored medications or pest control degree from Tuskegee University in baits have an appealing taste. Because 1994. In 1996, following experience in the average weight of the adult ferret small animal practices in Tennessee and is less than 2 kg, even small amounts in West Virginia, Dr. Richardson joined of toxins can be dangerous when the ASPCA National Animal Poison ingested. Therefore, prompt treatment Control Center as a Veterinary Poison of toxicoses is essential. Information Specialist. Rachel Balabuszko, CVT, joined the In cases of oral exposure, ferrets have ASPCA National Animal Poison Control the ability to vomit. However, the Center as a Certified Veterinary length of time since ingestion of the Ferrets can be restrained by scruffing Technician in 1998, after receiving her toxicant, the ferret’s age, its previous the loose skin on the back of the neck. associate degree in veterinary technol- medical history, and the type of ogy from Parkland College. poison ingested all affect the decision to induce emesis. Tom Schaefges Photography Sidney, Illinois [email protected] EXOTIC DVM VOLUME 2.4 2000 23 CLINICIAN’S NOTEBOOK STEPS IN MANAGING FERRET TOXICOSES START ASSESS THE SITUATION STABILIZE THE FERRET ✖ Is the ferret seizuring? ✖ Administer oxygen if necessary ✖ Is the ferret breathing? ✖ Control seizures ✖ What is the heart rate? ✖ Correct any cardiovascular ✖ What color are the mucous abnormality membranes? Table 1. -
Magnesium Sulfate for Neuroprotection Practice Guideline
[Type text] [Type text] Updated June 2013 Magnesium Sulfate for Neuroprotection Practice Guideline I. Background: Magnesium sulfate has been suggested to have neuro-protective effect in retrospective studies from 1987 and 1996. Since that time three randomized control trials have been performed to assess magnesium therapy for fetal neuroprotection. These studies have failed to demonstrate statistically significant decrease in combined outcome of cerebral palsy and death or improved overall neonatal survival. However, these results did demonstrate a significant decrease in cerebral palsy of any severity by 30%, particularly moderate-severe cerebral palsy (40-45%). The number needed to treat at less than 32 weeks gestation is 56. The presumptive mechanism of action for magnesium sulfate focuses on the N-methyl-D-aspartate receptor. Additional magnesium effects include calcium channel blockade resulting in cerebrovascular relaxation and magnesium mediated decreases in free radical production and reductions in the production of inflammatory cytokines. Magnesium sulfate should not be used as a tocolytic simply because of the potential for neuro-protective effects. In a recent committee opinion, ACOG states “the available evidence suggests that magnesium sulfate given before anticipated early preterm birth reduces the risk of cerebral palsy in surviving infants” but specific guidelines should be established. “The U.S. FDA has recently changed the classification of magnesium sulfate injection from Category A to Category D. However, this change was based on a small number of neonatal outcomes in cases in which the average duration of exposure was 9.6 weeks. The ACOG Committee on Obstetric Practice and the Society for Maternal-Fetal Medicine continue to support the use of magnesium sulfate in obstetric care for appropriate conditions and for appropriate, short term (usually less than 48 hours) durations of treatment.” II.